John R. Frantz

All filings by John R. Frantz on record concern Nextgen Healthcare, Inc. We count 24 filings; the first trade dates from 17 August 2015 and the latest from 23 April 2021.

In open-market terms, that means 1 purchase worth €35k on one side and 3 sales worth €1.5M on the other. The net balance comes to €1.5M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 20 share grants. So far in 2021, the count stands at no purchases and 2 sales.

Most recently, on 26 April 2021, the filings show a share grant worth €189k in Nextgen Healthcare, Inc. The latest purchase dates back some time: it was published 3,988 days ago, on 9 December 2015. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.